Loading...

Eli Lilly and Company

LLY•NYSE
Healthcare
Drug Manufacturers - General
$883.96
$-33.69(-3.67%)
U.S. Market opens in 15h 23m

Eli Lilly and Company (LLY) Stock Overview

Explore Eli Lilly and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap835.4B
P/E Ratio38.57
EPS (TTM)$22.94
ROE0.98%
Fundamental Analysis

AI Price Forecasts

1 Month$811.60
3 Months$827.25
1 Year Target$1152.87

LLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Eli Lilly and Company (LLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1152.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.57 and a market capitalization of 835.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.65%
5-Day Change
-3.66%
1-Month Change
-2.09%
3-Month Change
-16.92%
6-Month Change
7.11%
Year-to-Date (YTD) Change
-17.73%
1-Year Change
2.84%
3-Year Change
130.64%
5-Year Change
372.27%
All-Time (Max) Change
31365.37%

Contact Information

https://www.lilly.com
317 276 2000
Lilly Corporate Center, Indianapolis, IN, 46285

Company Facts

47,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions